# China NMPA Drug Inspection - Guangxi Wuzhou Sanjian Pharmaceutical Co., Ltd. - Compound Stemona Cough Granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangxi-wuzhou-sanjian-pharmaceutical-co-ltd/a412ded9-0a66-45a9-9b1d-c9065bca0ee5/
Source feed: China

> China NMPA drug inspection for Guangxi Wuzhou Sanjian Pharmaceutical Co., Ltd. published October 29, 2020. Drug: Compound Stemona Cough Granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement of the Results of the Fourth Guangxi Drug Quality Spot Check in 2020 (No. 11 of 2020)
- Company Name: Guangxi Wuzhou Sanjian Pharmaceutical Co., Ltd.
- Publication Date: 2020-10-29
- Drug Name: Compound Stemona Cough Granules
- Inspection Finding: Non-compliant with regulations [Microbiological Limits]
- Action Taken: Relevant regulatory authorities have taken control measures against non-compliant products and are investigating and punishing them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/guangxi-wuzhou-sanjian-pharmaceutical-co-ltd/9b2d8a6f-74c8-40b7-9e4d-b0156adc802f/